Cargando…
A nanobody-based tracer targeting DPP6 for non-invasive imaging of human pancreatic endocrine cells
There are presently no reliable ways to quantify endocrine cell mass (ECM) in vivo, which prevents an accurate understanding of the progressive beta cell loss in diabetes or following islet transplantation. To address this unmet need, we coupled RNA sequencing of human pancreatic islets to a systems...
Autores principales: | Balhuizen, Alexander, Massa, Sam, Mathijs, Iris, Turatsinze, Jean-Valery, De Vos, Jens, Demine, Stéphane, Xavier, Catarina, Villate, Olatz, Millard, Isabelle, Egrise, Dominique, Capito, Carmen, Scharfmann, Raphaël, In’t Veld, Pieter, Marchetti, Piero, Muyldermans, Serge, Goldman, Serge, Lahoutte, Tony, Bouwens, Luc, Eizirik, Decio L., Devoogdt, Nick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680294/ https://www.ncbi.nlm.nih.gov/pubmed/29123178 http://dx.doi.org/10.1038/s41598-017-15417-2 |
Ejemplares similares
-
Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer
por: D’Huyvetter, Matthias, et al.
Publicado: (2014) -
Imaging of Human Insulin Secreting Cells with Gd-DOTA-P88, a Paramagnetic Contrast Agent Targeting the Beta Cell Biomarker FXYD2γa
por: Demine, Stéphane, et al.
Publicado: (2018) -
Targeted alpha therapy using short-lived alpha-particles and the promise of nanobodies as targeting vehicle
por: Dekempeneer, Yana, et al.
Publicado: (2016) -
Immunogenicity Risk Profile of Nanobodies
por: Ackaert, Chloé, et al.
Publicado: (2021) -
Targeted Radionuclide Therapy with A (177)Lu-labeled Anti-HER2 Nanobody
por: D'Huyvetter, Matthias, et al.
Publicado: (2014)